Hyperbolic Tapering off Antidepressants Limits Withdrawal
New research by Jim van Os and Peter Groot finds that using hyperbolic tapering to discontinue antidepressants reduces withdrawal effects.
Prescribers Often Fail to Support Patients Discontinuing Antidepressants, Study Finds
Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.
Global Survey Leads to New Recommendations for Deprescribing Psychiatric Drugs
Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.
New Guidance on Antidepressant Withdrawal for Doctors in the UK
New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.
Researchers Seek Standardized and Safe Antidepressant Tapering Protocol
A new study promotes the use of a standardized approach to antidepressant tapering.
Gradual Tapering Recommended for Antidepressant Discontinuation
A new literature review reinforces the need to “down-titrate” or taper antidepressants, especially drugs like Celexa and Paxil.
Antidepressant Withdrawal Linked to Suicide Attempt in Case Study
Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.
A Different Psychiatry Is Needed for Discontinuing Antidepressants
The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.
Research Explores the Experience of Benzodiazepine Withdrawal
A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.
How to Distinguish Antidepressant Withdrawal from Relapse
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
Many Service Users Interested in Decreasing Antipsychotic Use with Professional Help
New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.
Official Guidelines on Antidepressant Discontinuation Fail Practitioners and Patients
A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.
How Providers Can Support Psychiatric Drug Discontinuation
Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.
What Helps Long-Term Users of Benzodiazepines and Z-Drugs Discontinue?
Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.
Withdrawal Symptoms Cloud Findings of Antidepressant “Relapse” Trial
Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.
Researchers Provide Guidance for Reducing and Stopping Psychiatric Drugs
New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.
New Rating Tool for Tapering Antidepressants and Antipsychotics
Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.
Tapered Antipsychotic Withdrawal Mitigates Risk of Psychotic Symptoms
Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.
“Relapse” in Antidepressant Trials Likely Caused by Sudden Withdrawal
A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.
Jim van Os and Peter Groot: When Assessing Antidepressant Withdrawal Methods, RCTs Fall Short
Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study” published in the journal Therapeutic Advances in Psychopharmacology.
Sudden Antipsychotic Withdrawal—Not Low Dose—Leads to Relapse
A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.
Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read
A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.
Mental Health Survival Kit, Chapter 4: Withdrawing from Psychiatric Drugs (Part 6)
Peter Gøtzsche gives advice on what withdrawal symptoms may look like and explains the dangers of—and alternatives to—forced treatment.
Mental Health Survival Kit, Chapter 4: Withdrawing from Psychiatric Drugs (Part 5)
Withdraw from psychiatric drugs at your own speed—according to what you feel. Don’t reduce again before you feel stabilised on the previous dose.
Mental Health Survival Kit, Chapter 4: Withdrawing from Psychiatric Drugs (Part 4)
Psychiatrists have made hundreds of millions of people dependent on psychiatric drugs and yet have done virtually nothing to find out how to help the patients come off them again.